PATRICK FOURTEAU Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PATRICK FOURTEAU.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PATRICK FOURTEAU. PATRICK FOURTEAU is a Director in REPROS THERAPEUTICS INC. ($RPRX) and a President and CEO in REPROS THERAPEUTICS INC. ($RPRX) and a CEO and President in SCIELE PHARMA, INC. ($FHRX) and a Director in Insys Therapeutics, Inc. ($INSY).
Companies in which PATRICK FOURTEAU is an Insider
Insys Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PATRICK FOURTEAU: Director
Holdings: 69,682 shares
Current Value: $694,033
Latest Transaction: Aug 04 2017
$INSY Market Capitalization: $694.73M
$INSY Previous Close: $9.96
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
REPROS THERAPEUTICS INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PATRICK FOURTEAU: President and CEO, Director
Holdings: 27,779 shares
Current Value: $33,890
Latest Transaction: Jan 31 2018
$RPRX Market Capitalization: $30.76M
$RPRX Previous Close: $1.22
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SCIELE PHARMA, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PATRICK FOURTEAU: CEO and President
Holdings: 330,424 shares
Latest Transaction: Dec 14 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of PATRICK FOURTEAU
Sentiment: All, INSY, RPRX, FHRX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31 2018 | RPRX | REPROS THERAPEUTIC ... | FOURTEAU PATRICK | Director | Option Exercise | D | 0.32 | 5,000 | 1,600 | 0 | |
| Jan 31 2018 | RPRX | REPROS THERAPEUTIC ... | FOURTEAU PATRICK | Director | Sell | D | 0.67 | 27,779 | 18,612 | 0 | 27.8 K to 0 (-100.00 %) |
| Jan 31 2018 | RPRX | REPROS THERAPEUTIC ... | FOURTEAU PATRICK | Director | Sell | U | 0.67 | 12,221 | 8,188 | 27,779 | 40 K to 27.8 K (-30.55 %) |
| Sep 18 2017 | RPRX | REPROS THERAPEUTIC ... | FOURTEAU PATRICK | President and CEO | Option Exercise | A | 0.32 | 5,000 | 1,600 | 5,000 | |
| Aug 04 2017 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Option Exercise | M | 1.62 | 10,000 | 16,200 | 63,770 | |
| Aug 04 2017 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Buy | M | 1.62 | 10,000 | 16,200 | 69,682 | 59.7 K to 69.7 K (+16.76 %) |
| May 26 2017 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Option Exercise | M | 3.63 | 10,000 | 36,300 | 50,000 |